Vancouver, British Columbia – September 28, 2015 - Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt/Xetra®: ZSB), (the “Company”) is pleased to announce that it has generated a total of $1,024,328 as a result of share purchase warrant exercises of 6,120,800 shares and the share purchase option exercise of 300,000 shares over the past week. The warrants had an expiry date of September 19, 2015.
“This cash injection provides the necessary funding for the Company until completion of a licensing deal with SBM-TFC-1067,” said Dr. Howard Verrico, CEO and Chairman of Sirona.
Net proceeds from the warrants exercised will be used to finance Sirona’s cosmeceutical and therapeutic programs utilizing the Company’s innovative platform technology, as well as for general corporate purposes For more information regarding this press release, please contact:
Christopher Hopton, CFO
Sirona Biochem Corp.
Phone: 1.604.282.6064
Email: chopton@sironabiochem.com
Help employers find you! Check out all the jobs and post your resume.